Physician

Andrew Marc Schneider, M.D.

According to 2025 Medicare claims, Andrew Schneider, M.D. (NPI: 1548276140) practices hematology/oncology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SOUTH FLORIDA ONCOLOGY AND HEMATOLOGY CONSULTANTS LLC (NPI: 1700891256; TIN: 650577436) and primary practice location at 33321-2909.

Schneider's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 136 traditional Medicare patients, billed 68,995 HCPCS/CPT codes, and received $1,232,926 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 866 prescription claims across 224 beneficiaries totaling $3,793,899 in drug costs, led by Ibrance (Palbociclib). Open Payments data shows 41 records totaling $159,969. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $490,088 and ending at $1,232,926. Concurrently, Part D prescription costs have risen steadily, from $1,692,103 to $3,793,899. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	148	50,326	$490,088
2016	129	28,086	$406,778
2017	140	27,087	$508,055
2018	163	24,274	$409,031
2019	146	23,634	$503,376
2020	87	48,745	$699,761
2021	97	55,942	$400,128
2022	110	45,635	$454,487
2023	122	46,021	$478,170
2024	136	68,995	$1,232,926

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	387	2,357	$1,692,103
2016	337	2,095	$2,095,234
2017	356	1,773	$1,984,398
2018	331	1,772	$1,554,110
2019	357	1,714	$1,581,839
2020	330	1,576	$1,692,257
2021	300	1,314	$2,153,397
2022	260	902	$2,435,024
2023	210	790	$2,519,595
2024	224	866	$3,793,899

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	181	$70
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	30	56	$50
96372	Injection of drug or substance under skin or into muscle	27	103	$11
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	93	311	$8
J1200	Injection, diphenhydramine hcl, up to 50 mg	23	103	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	37	1,036	$607,462
Lenalidomide	Lenalidomide	29	812	$380,182
Venclexta	Venetoclax	26	760	$368,239
Xtandi	Enzalutamide	15	450	$214,438
Jakafi	Ruxolitinib Phosphate	11	330	$194,958

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$71	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	37	$159,898	Boehringer Ingelheim Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Marc Schneider, M.D.?

Tedicare shows public-source Medicare data for Andrew Marc Schneider, M.D. (NPI 1548276140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Marc Schneider, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Marc Schneider, M.D.?

Andrew Marc Schneider, M.D. is linked to SOUTH FLORIDA ONCOLOGY AND HEMATOLOGY CONSULTANTS LLC (billing NPI 1700891256) in the available physician profile data.

Does Andrew Marc Schneider, M.D. have Open Payments data?

Andrew Marc Schneider, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.